FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

3694111000001105: Endoxana 50mg tablets (Baxter Healthcare Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
17574701000001117 Endoxana 50mg tablets (Baxter Healthcare Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
17574801000001114 Endoxana 50mg tablets (Baxter Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Is a Product containing precisely cyclophosphamide 50 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has active ingredient Cyclophosphamide false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Is a Endoxana true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has specific active ingredient Cyclophosphamide monohydrate false Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has specific active ingredient Cyclophosphamide monohydrate true Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) Has basis of strength substance Cyclophosphamide true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Is pack of False Endoxana 50mg tablets (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier
Endoxana 50mg tablets (Baxter Healthcare Ltd) 100 tablet 10 x 10 tablets Has AMP True Endoxana 50mg tablets (Baxter Healthcare Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start